Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia

Cancer

Volumn 120, Issue 4, 2014, Pages 521-529

  Lee, Hun Ju ^b   Muindi, Josephia R ^a   Tan, Wei ^a   Hu, Qiang ^a   Wang, Dan ^a   Liu, Song ^a   Wilding, Gregory E ^a   Ford, Laurie A ^a   Sait, Sheila N J ^a   Block, Annemarie W ^a   Adjei, Araba A ^a   Barcos, Maurice ^a   Griffiths, Elizabeth A ^a   Thompson, James E ^a   Wang, Eunice S ^a   Johnson, Candace S ^a   Trump, Donald L ^a   Wetzler, Meir ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

acute myeloid leukemia; microRNA; outcome; single nucleotide polymorphism; vitamin D

Indexed keywords

ACUTE MYELOID LEUKEMIA; MICRORNA; OUTCOME; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN D;

ADULT; AGED; AGED, 80 AND OVER; CALCIFEDIOL; CHOLECALCIFEROL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTORS, CALCITRIOL; TRANSCRIPTOME; TREATMENT OUTCOME;

EID: 84893723148     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28368     Document Type: Article

References (30)

1. Hassan IB, Islam SI, Alizadeh H, et al. Acute leukemia among the adult population of United Arab Emirates: an epidemiological study. Leuk Lymphoma. 2009; 50: 1138-1147.
2. Al-Turki HA, Sadat-Ali M, Al-Elq AH, Al-Mulhim FA, Al-Ali AK,. 25-Hydoxyvitamin D levels among healthy Saudi Arabian women. Saudi Med J. 2008; 29: 1765-1768.
3. Miyaura C, Abe E, Kuribayashi T, et al. 1 Alpha,25-dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Comm. 1981; 102: 937-943. (Pubitemid 12213816)
4. Drake MT, Maurer MJ, Link BK, et al. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol. 2010; 28: 4191-4198.
5. Shanafelt TD, Drake MT, Maurer MJ, et al. Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood. 2011; 117: 1492-1498.
6. Shimizu T, Taira N, Senou M, Takeda K,. Involvement of diverse protein kinase C isoforms in the differentiation of ML-1 human myeloblastic leukemia cells induced by the vitamin D3 analogue KH1060 and the phorbol ester TPA. Cancer Lett. 2002; 186: 67-74. (Pubitemid 35245328)
7. Wang X, Studzinski GP,. Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells. J Cell Biochem. 2001; 80: 471-482. (Pubitemid 32127462)
8. Ji Y, Kutner A, Verstuyf A, Verlinden L, Studzinski GP,. Derivatives of vitamins D2 and D3 activate 3 MAPK pathways and upregulate pRb expression in differentiating HL60 cells. Cell Cycle. 2002; 1: 410-415.
9. Hughes PJ, Brown G,. 1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway. J Cell Biochem. 2006; 98: 590-617. (Pubitemid 43727178)
10. Marcinkowska E, Garay E, Gocek E, Chrobak A, Wang X, Studzinski GP,. Regulation of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3. Exp Cell Res. 2006; 312: 2054-2065. (Pubitemid 43850930)
11. Studzinski GP, Garay E, Patel R, Zhang J, Wang X,. Vitamin D receptor signaling of monocytic differentiation in human leukemia cells: role of MAPK pathways in transcription factor activation. Curr Top Med Chem. 2006; 6: 1267-1271. (Pubitemid 44110915)
12. Rovira C, Guida MC, Cayota A,. MicroRNAs and other small silencing RNAs in cancer. IUBMB Life. 2010; 62: 859-868.
13. Orton SM, Morris AP, Herrera BM, et al. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr. 2008; 88: 441-447.
14. Hunter D, De Lange M, Snieder H, et al. Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res. 2001; 16: 371-378. (Pubitemid 32105418)
15. Touvier M, Chan DS, Lau R, et al. Meta-analyses of vitamin d intake, 25-hydroxyvitamin d status, vitamin d receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2011; 20: 1003-1016.
16. Chadha MK, Fakih M, Muindi J, et al. Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients. Prostate. 2011; 71: 368-372.
17. Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL,. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem. 1993; 39: 529-533. (Pubitemid 23099026)
18. Rosen CJ,. Clinical practice. Vitamin D insufficiency. N Engl J Med. 2011; 364: 248-254.
19. Adjei AA, Thomae BA, Prondzinski JL, Eckloff BW, Wieben ED, Weinshilboum RM,. Human estrogen sulfotransferase (SULT1E1) pharmacogenomics: gene resequencing and functional genomics. Br J Pharmacol. 2003; 139: 1373-1382. (Pubitemid 37174650)
20. Ma CX, Adjei AA, Salavaggione OE, et al. Human aromatase: gene resequencing and functional genomics. Cancer Res. 2005; 65: 11071-11082. (Pubitemid 41713378)
21. Leil TA, Endo C, Adjei AA, et al. Identification and characterization of genetic variation in the folylpolyglutamate synthase gene. Cancer Res. 2007; 67: 8772-8782. (Pubitemid 47437453)
22. Barrett JC, Fry B, Maller H, Daly MJ,. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21: 263-265. (Pubitemid 40202029)
23. Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol. 2003; 21: 4642-4649. (Pubitemid 46594039)
24. Benjamini Y, Hochberg Y,. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995; 57: 289-300.
25. Trump DL, Chadha MK, Sunga AY, et al. Vitamin D deficiency and insufficiency among patients with prostate cancer. BJU Int. 2009; 104: 909-914.
26. Lee HJ, Licht AS, Hyland AJ, et al. Is obesity a prognostic factor for acute myeloid leukemia outcome? Ann Hematol. 2012; 91: 359-365.
27. Whitman SP, Maharry K, Radmacher MD, et al. FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood. 2010; 116: 3622-3626.
28. Gocek E, Kielbinski M, Baurska H, Haus O, Kutner A, Marcinkowska E,. Different susceptibilities to 1,25-dihydroxyvitamin D3-induced differentiation of AML cells carrying various mutations. Leukemia Res. 2010; 34: 649-657.
29. Grande A, Manfredini R, Pizzanelli M, et al. Presence of a functional vitamin D receptor does not correlate with vitamin D3 phenotypic effects in myeloid differentiation. Cell Death Diff. 1997; 4: 497-505. (Pubitemid 127680685)
30. Salvatori B, Iosue I, Mangiavacchi A, et al. The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells [serial online]. Cell Death Dis. 2012; 3: e413.